<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0020">
 <label>20</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Zweifel</surname>
    <given-names>M</given-names>
   </string-name>, 
   <string-name>
    <surname>Jayson</surname>
    <given-names>GC</given-names>
   </string-name>, 
   <string-name>
    <surname>Reed</surname>
    <given-names>N</given-names>
   </string-name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Phase ii trial of combretastatin a4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer</article-title>. 
  <source>Ann Oncol</source>
  <year>2011</year>;
  <volume>22</volume>:
  <fpage>2036</fpage>–
  <lpage>41</lpage>.
  <pub-id pub-id-type="pmid">21273348</pub-id>
 </mixed-citation>
</ref>
